HuagongsheHuagongshe Chemistry Print Report · For research reference only
3-((1H-imidazol-1-yl)methyl)-6-methyl-2-p-tolylimidazo[1,2-a]pyridine → HCID 67028977, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 3-((1H-imidazol-1-yl)methyl)-6-methyl-2-p-tolylimidazo[1,2-a]pyridine | HCID 58337071 | — |
| Reactant | HCID 67028922 | HCID 67028922 | — |
| Reactant | HCID 178418936 | HCID 178418936 | — |
| Product | HCID 67028977 | HCID 67028977 | — |
Reaction Steps
The title compound was prepared according to Method A and the experimentals described for compound 1 from 3-(chloromethyl)-2-(4-chlorophenyl)imidazo[1,2-b]pyridazine hydrochloride and 1H-1,2,3-triazole. 1H-NMR (400 MHz, CDCl3, δ) 8.17 (d, J=6.8 Hz, 1H), 8.00 (s, 1H), 7.68 (m, 3H), 7.52 (m, 2H), 7.33 (m, 1H), 7.26 (m, 1H), 6.93 (m, 1H), 5.74 (s, 2H) ppm; m/e 310.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08497278B2 |
| Source dataset | uspto-grants-2013_07 |
| ORD ID | ord-45bcc9d4100a4208a247edddcc27b45e |
| Source note | uspto-grants-2013_07 |